Gender effect on metformin and sitagliptin [Regulatives / Guidelines]

posted by khageswara Rao – India, 2022-03-01 07:26 (120 d 10:05 ago) – Posting: # 22816
Views: 547

Dear All,

As per updated guidelines

If a drug product is intended for use in both sexes, the applicant should include similar proportions of males and females in the study or provide a justification supporting the use of a single-sex population.

for metformin and Sitagliptin we have enrolled only male subjects so please provide the justification on the same of gender effect. with references.

Your quick response will much helpful

Thanks in advance.

Complete thread:

UA Flag
Activity
 Admin contact
22,181 posts in 4,647 threads, 1,572 registered users;
online 8 (0 registered, 8 guests [including 6 identified bots]).
Forum time: Wednesday 18:31 CEST (Europe/Vienna)

Nerds don’t just happen to dress informally.
They do it too consistently.
Consciously or not, they dress informally
as a prophylactic measure against stupidity.    Paul Graham

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5